Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ·Healthcare·Biotechnology
$32.78
-1.00%
Mkt Cap $2.26B
Analyst Ratings
Buy
6
Hold
2
Sell
0
Price Target (27 analysts)
$49.00
Range $34.00 – $70.00
Implied Upside
+49.5%
Consensus $49.00 vs current $32.78